Expression of recombinant human flavin monooxygenase and moclobemide-N-oxide synthesis on multi-mg scale

Steven P. Hanlon; Andrea Camattari; Sandra Abad; Anton Glieder; Beat Wirz; Matthias Kittelmann; Stephan Lütz; Margit Winkler

doi:DOI: 10.1039/C2CC17878H

Expression of recombinant human flavin monooxygenase and moclobemide-N-oxide synthesis on multi-mg scale

Steven P. Hanlon, Andrea Camattari, Sandra Abad, Anton Glieder, Beat Wirz, Matthias Kittelmann, Stephan Lütz, Margit Winkler

Publikation: Beitrag in einer Fachzeitschrift › Artikel › Begutachtung

Abstract

A panel of human flavin monooxygenases were heterologously expressed in E. coli to obtain ready-to-use biocatalysts for the in vitro preparation of human drug metabolites. Moclobemide-N-oxide (65 mg) was the first high-priced metabolite prepared with recombinant hFMO3 on the multi-milligram scale.

Originalsprache	englisch
Seiten (von - bis)	6001-6003
Seitenumfang	3
Fachzeitschrift	Chemical Communications
Jahrgang	48
Ausgabenummer	48
DOIs	https://doi.org/DOI: 10.1039/C2CC17878H https://doi.org/10.1039/c2cc17878h
Publikationsstatus	Veröffentlicht - 2012

Fields of Expertise

Human- & Biotechnology

Treatment code (Nähere Zuordnung)

Experimental
Application

Zugriff auf Dokument

Dieses zitieren

@article{e51cb51db3884fbc86ea40e5893b5b1b,

title = "Expression of recombinant human flavin monooxygenase and moclobemide-N-oxide synthesis on multi-mg scale",

abstract = "A panel of human flavin monooxygenases were heterologously expressed in E. coli to obtain ready-to-use biocatalysts for the in vitro preparation of human drug metabolites. Moclobemide-N-oxide (65 mg) was the first high-priced metabolite prepared with recombinant hFMO3 on the multi-milligram scale.",

keywords = "Enzymes, Escherichia coli, Flavins, Humans, Mixed Function Oxygenases, Moclobemide, Journal Article, Research Support, Non-U.S. Gov't",

author = "Hanlon, {Steven P.} and Andrea Camattari and Sandra Abad and Anton Glieder and Beat Wirz and Matthias Kittelmann and Stephan L{\"u}tz and Margit Winkler",

year = "2012",

doi = "DOI: 10.1039/C2CC17878H",

language = "English",

volume = "48",

pages = "6001--6003",

journal = "Chemical Communications",

issn = "1364-548X",

publisher = "Royal Society of Chemistry",

number = "48",

}

TY - JOUR

T1 - Expression of recombinant human flavin monooxygenase and moclobemide-N-oxide synthesis on multi-mg scale

AU - Hanlon, Steven P.

AU - Camattari, Andrea

AU - Abad, Sandra

AU - Glieder, Anton

AU - Wirz, Beat

AU - Kittelmann, Matthias

AU - Lütz, Stephan

AU - Winkler, Margit

PY - 2012

Y1 - 2012

N2 - A panel of human flavin monooxygenases were heterologously expressed in E. coli to obtain ready-to-use biocatalysts for the in vitro preparation of human drug metabolites. Moclobemide-N-oxide (65 mg) was the first high-priced metabolite prepared with recombinant hFMO3 on the multi-milligram scale.

AB - A panel of human flavin monooxygenases were heterologously expressed in E. coli to obtain ready-to-use biocatalysts for the in vitro preparation of human drug metabolites. Moclobemide-N-oxide (65 mg) was the first high-priced metabolite prepared with recombinant hFMO3 on the multi-milligram scale.

KW - Enzymes

KW - Escherichia coli

KW - Flavins

KW - Humans

KW - Mixed Function Oxygenases

KW - Moclobemide

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - DOI: 10.1039/C2CC17878H

DO - DOI: 10.1039/C2CC17878H

M3 - Article

C2 - 22576266

SN - 1364-548X

VL - 48

SP - 6001

EP - 6003

JO - Chemical Communications

JF - Chemical Communications

IS - 48

ER -

Expression of recombinant human flavin monooxygenase and moclobemide-N-oxide synthesis on multi-mg scale

Abstract

Fields of Expertise

Treatment code (Nähere Zuordnung)

Zugriff auf Dokument

Fingerprint

Dieses zitieren